ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,173,000 | -29.9% | 29,029 | -0.1% | 0.01% | -28.6% |
| Q2 2015 | $1,673,000 | -1.5% | 29,070 | +8.9% | 0.01% | 0.0% |
| Q1 2015 | $1,699,000 | +3.1% | 26,688 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $1,648,000 | +39.5% | 26,688 | -12.3% | 0.01% | +40.0% |
| Q3 2014 | $1,181,000 | +3.9% | 30,416 | -7.8% | 0.01% | 0.0% |
| Q2 2014 | $1,137,000 | -20.3% | 33,004 | 0.0% | 0.01% | -16.7% |
| Q1 2014 | $1,426,000 | +8.4% | 33,004 | 0.0% | 0.01% | +9.1% |
| Q4 2013 | $1,315,000 | +6.1% | 33,004 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $1,239,000 | +39.7% | 33,004 | 0.0% | 0.01% | +37.5% |
| Q2 2013 | $887,000 | – | 33,004 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |